Welgene Biotech Co.,Ltd. (TPEX:6661)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
18.60
-0.50 (-2.62%)
At close: Feb 11, 2026

Welgene Biotech Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
433555521517570749
Market Cap Growth
-19.66%6.49%0.68%-9.20%-23.98%29.29%
Enterprise Value
350499500317410627
Last Close Price
18.6023.8022.3522.0223.6933.69
PE Ratio
265.74501.03-54.1641.5825.17
PS Ratio
1.191.721.861.611.821.88
PB Ratio
1.481.881.741.701.842.97
P/TBV Ratio
1.501.931.791.711.852.99
P/FCF Ratio
15.2110.82-21.0682.9420.90
P/OCF Ratio
9.289.89-10.0650.6717.94
EV/Sales Ratio
0.961.551.780.991.311.58
EV/EBITDA Ratio
12.8034.3152.7612.9718.4614.83
EV/EBIT Ratio
---18.3428.6917.80
EV/FCF Ratio
12.309.73-12.9059.7217.48
Debt / Equity Ratio
0.570.440.510.170.080.12
Debt / EBITDA Ratio
6.064.666.771.420.720.55
Debt / FCF Ratio
5.832.53-2.083.470.82
Net Debt / Equity Ratio
-0.30-0.33-0.14-0.55-0.64-0.60
Net Debt / EBITDA Ratio
-6.25-6.65-4.51-6.81-8.98-3.59
Net Debt / FCF Ratio
-3.08-1.881.52-6.77-29.06-4.24
Asset Turnover
0.690.600.570.750.801.02
Inventory Turnover
5.204.123.675.917.9110.51
Quick Ratio
2.262.021.932.532.722.55
Current Ratio
2.622.342.392.892.992.76
Return on Equity (ROE)
0.49%0.24%-1.04%3.11%4.87%11.83%
Return on Assets (ROA)
-0.02%-0.10%-0.54%2.51%2.28%5.63%
Return on Invested Capital (ROIC)
-0.05%-0.21%-2.16%9.82%11.18%27.75%
Return on Capital Employed (ROCE)
0.00%-0.20%-1.00%5.20%4.60%13.30%
Earnings Yield
0.38%0.20%-0.51%1.85%2.40%3.97%
FCF Yield
6.57%9.24%-5.39%4.75%1.21%4.78%
Dividend Yield
---0.82%2.03%3.27%
Payout Ratio
---118.16%187.38%93.25%
Buyback Yield / Dilution
--0.10%-0.93%-10.99%0.01%
Total Shareholder Return
--0.10%-0.11%-8.97%3.28%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.